KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹9.01 Cr | ₹9.32 Cr | ₹7.87 Cr | ₹7.08 Cr | ₹6.27 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of KOPRAN ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹9.01 Cr |
| Mar2025 | ₹9.32 Cr |
| Mar2024 | ₹7.87 Cr |
| Mar2023 | ₹7.08 Cr |
| Mar2022 | ₹6.27 Cr |
How is Deferred Tax Assets / Liabilities of KOPRAN Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹9.01 Cr | -3.28 | |
| Mar2025 | ₹9.32 Cr | 18.45 | |
| Mar2024 | ₹7.87 Cr | 11.15 | |
| Mar2023 | ₹7.08 Cr | 12.87 | |
| Mar2022 | ₹6.27 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹912.1 Cr | -5.1% | -2.9% | 11% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -5.1% |
-2.9% |
11% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses